CD86 and arthritic joint disease: Moreover, the IGF2BP3 KO plus CEL group did not show further inhibition effects on the proportion of F4/80+CD11b+CD86+ M1 macrophage, compared with that in the IGF2BP3 KO arthritis mice (Figure S7D, Figure 7E).